Protara Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:TARA) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 203.16 M172.6 M113.29 M78.95 M181.45 M209.47 M 총 부채 3.91 M10.68 M11.21 M10.63 M14.32 M13.06 M 자본금 총액 199.24 M161.91 M102.08 M68.32 M167.13 M196.41 M 총 부채 및 주주자본 203.16 M172.6 M113.29 M78.95 M181.45 M209.47 M 총부채 —————— 순부채 ——————

뉴스

Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations - Slideshow (NASDAQ:TARA) 2026-05-20

Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations Transcript

TD Cowen, Protara Therapeutics 투자의견 유지

TD Cowen reiterates Protara Therapeutics stock rating on trial data

JP모건, 프로테라 테라퓨틱스에 ’비중확대’ 의견 제시

JP모건, 프로테라 테라퓨틱스에 ’비중확대’ 개시

JPMorgan initiates Protera Therapeutics stock at Overweight

Protara Therapeutics, Inc. (TARA) Presents at 2026 ASCO Genitourinary Cancers Symposium - Slideshow (NASDAQ:TARA) 2026-02-26

AMD and Keysight Technologies among market cap stock movers on Tuesday

AMD, IBM among market cap stock movers on Tuesday

What's Going On With Protara Therapeutics Stock Tuesday? - Protara Therapeutics (NASDAQ:TARA)

Protara Therapeutics, 임상 데이터 발표 후 급락